{"id":"ba28973f-6a33-4cce-a22f-d34a99443937","companyId":"cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed","modelName":"Epione","slug":"epione","description":"French medical robotics company developing the [Epione](/models/epione) robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former [Medtech SA](/companies/medtech-sa) engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.quantumsurgical.com/news/fda-clears-quantum-surgicals-epione-robot-for-all-abdominal-cancers","title":"FDA clears Quantum Surgical's Epione robot for all abdominal cancers","sourceName":"Quantum Surgical"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"abdominal ablation indication"},{"label":"CE marked","value":"abdomen, chest, musculoskeletal"},{"label":"Acquired NeuWave Medical","value":"Feb 2026"},{"label":"CEO","value":"Bertin Nahum (President & Co-founder)"},{"label":"Group CEO","value":"Kurt Azarbarzin (Precision IO Group, appointed Feb 2026)"},{"label":"Co-founders","value":"Bertin Nahum, Fernand Badano, Lucien Blondel, Sophie Roca"},{"label":"Total funding","value":"approx 90M USD (50M EUR equity + 30M EUR EIB loan)"},{"label":"FDA clearance","value":"510(k) K223758 for abdominal tumor ablation"},{"label":"CE mark","value":"abdomen, lung, and musculoskeletal indications"},{"label":"Parent company","value":"Precision IO Group Inc. (since Feb 2026)"},{"label":"Patients treated","value":"1400+ (as of 2026)"}],"createdAt":"2026-07-06T14:11:34.647Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/epione","url":"https://registry.deploy.report/models/epione","name":"Epione","description":"French medical robotics company developing the [Epione](/models/epione) robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former [Medtech SA](/companies/medtech-sa) engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.","identifier":"ba28973f-6a33-4cce-a22f-d34a99443937","category":"surgical","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}